Trial intelligence / Profile preview

Lutropin alfa (Luveris) mid-follicular addition in controlled ovarian stimulation for ovarian ageing

2004-001503-36Phase 2Completed

Sponsor
Serono España
Start
Oct 2004
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial of lutropin alfa in hypofertility (2 arms), sponsored by Serono España. Primary endpoint: Proportion of metaphase II oocytes retrieved. Started Oct 2004; status: completed.

02

Drugs

lutropin alfa
03

Conditions

hypofertility

Beyond the preview

Go deeper on 2004-001503-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001503-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call